A new mandate takes effect in Maine in January that affects the member cost sharing for oral medications used to treat cancer. The new law requires insurers to cover oral chemotherapies on a basis no less favorable than coverage applied to intravenously administered or injected cancer medications.
As a result, for plans other than Best Buy HSA plans, Harvard Pilgrim will now be covering oral medications for cancer treatment obtained at a pharmacy at no charge to members. For Best Buy HSA plans, the in-network deductible that pertains to intravenously administered or injected cancer medications will also apply to oral chemotherapies.
The new mandate applies to fully-insured plans purchased or renewed on or after January 1, 2015.